BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 20691045)

  • 1. Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study.
    Musoke PM; Mudiope P; Barlow-Mosha LN; Ajuna P; Bagenda D; Mubiru MM; Tylleskar T; Fowler MG
    BMC Pediatr; 2010 Aug; 10():56. PubMed ID: 20691045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of highly active antiretroviral therapy in HIV-infected Indian children.
    Mukherjee A; Shah N; Singh R; Vajpayee M; Kabra SK; Lodha R
    BMC Infect Dis; 2014 Dec; 14():701. PubMed ID: 25539905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
    Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
    HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Côte d'Ivoire.
    Fassinou P; Elenga N; Rouet F; Laguide R; Kouakoussui KA; Timite M; Blanche S; Msellati P
    AIDS; 2004 Sep; 18(14):1905-13. PubMed ID: 15353976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective study.
    Mutwa PR; Boer KR; Asiimwe-Kateera B; Tuyishimire D; Muganga N; Lange JM; van de Wijgert J; Asiimwe A; Reiss P; Geelen SP
    PLoS One; 2014; 9(11):e111948. PubMed ID: 25365302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth in HIV-infected children on long-term antiretroviral therapy.
    Feucht UD; Van Bruwaene L; Becker PJ; Kruger M
    Trop Med Int Health; 2016 May; 21(5):619-29. PubMed ID: 26914715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological and Virological Responses to Highly Active Antiretroviral Therapy in HIV-1 Infected Children.
    Singh R; Mukherjee A; Singla M; Das BK; Kabra SK; Lodha R
    Indian J Pediatr; 2017 Dec; 84(12):893-896. PubMed ID: 28875475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term virological outcome in children receiving first-line antiretroviral therapy.
    Chandrasekaran P; Shet A; Srinivasan R; Sanjeeva GN; Subramanyan S; Sunderesan S; Ramesh K; Gopalan B; Suresh E; Poornagangadevi N; Hanna LE; Chandrasekar C; Wanke C; Swaminathan S
    AIDS Res Ther; 2018 Nov; 15(1):23. PubMed ID: 30477526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral load predicts new world health organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy, independent of CD4 T lymphocyte value.
    Oliveira R; Krauss M; Essama-Bibi S; Hofer C; Robert Harris D; Tiraboschi A; de Souza R; Marques H; Succi R; Abreu T; Della Negra M; Hazra R; Mofenson LM; Siberry GK;
    Clin Infect Dis; 2010 Dec; 51(11):1325-33. PubMed ID: 21039218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-year clinical and immune outcomes in human immunodeficiency virus-infected children who reconstitute CD4 T cells without control of viral replication after combination antiretroviral therapy.
    Ghaffari G; Passalacqua DJ; Caicedo JL; Goodenow MM; Sleasman JW
    Pediatrics; 2004 Nov; 114(5):e604-11. PubMed ID: 15492356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of height and weight velocity as a part of the composite endpoint in pediatric HIV.
    Benjamin DK; Miller WC; Benjamin DK; Ryder RW; Weber DJ; Walter E; McKinney RE
    AIDS; 2003 Nov; 17(16):2331-6. PubMed ID: 14571184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program.
    Puthanakit T; Oberdorfer A; Akarathum N; Kanjanavanit S; Wannarit P; Sirisanthana T; Sirisanthana V
    Clin Infect Dis; 2005 Jul; 41(1):100-7. PubMed ID: 15937769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of highly active antiretroviral therapy on nutritional and immunologic status in HIV-infected children in the low-income country of Ethiopia.
    Ebissa G; Deyessa N; Biadgilign S
    Nutrition; 2016 Jun; 32(6):667-73. PubMed ID: 26875999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival and immuno-virological response of African HIV-1-infected children to highly active antiretroviral therapy regimens.
    Rouet F; Fassinou P; Inwoley A; Anaky MF; Kouakoussui A; Rouzioux C; Blanche S; Msellati P;
    AIDS; 2006 Nov; 20(18):2315-9. PubMed ID: 17117017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Body Composition and Other Clinical Factors with Incomplete Immune Response after Highly Active Antiretroviral Therapy.
    Sun PT; Yu W; Li TS; Lin Q; Guo FP; Zhou XH; Du GY; Xu Y; Guan WM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):459-464. PubMed ID: 28877821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
    Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
    Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy.
    Puthanakit T; Kerr S; Ananworanich J; Bunupuradah T; Boonrak P; Sirisanthana V
    Pediatr Infect Dis J; 2009 Jun; 28(6):488-92. PubMed ID: 19504731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of first-line antiretroviral therapy failure in HIV-infected Thai children and adolescents.
    Bunupuradah T; Sricharoenchai S; Hansudewechakul R; Klinbuayaem V; Teeraananchai S; Wittawatmongkol O; Akarathum N; Prasithsirikul W; Ananworanich J;
    Pediatr Infect Dis J; 2015 Mar; 34(3):e58-62. PubMed ID: 25478649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort.
    Wamalwa DC; Obimbo EM; Farquhar C; Richardson BA; Mbori-Ngacha DA; Inwani I; Benki-Nugent S; John-Stewart G
    BMC Pediatr; 2010 May; 10():33. PubMed ID: 20482796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.